Breaking News
Top News
-
Lilly seals up to $7.8 billion deal for Centessa in sleep disorder bet
-
Stock Market Today: Futures Surge as Indexes Set to End Worst Quarter Since 2022; Trump Reportedly Willing to End War Without Reopening Strait
-
Biogen to Acquire Apellis Pharmaceuticals for $5.6 Billion
-
This fire safety stock is in the dumps. UBS says it’s time to buy
-
US Stock Futures Jump as Trump Signals Desire to End Iran War
-
Low transparency in the private-credit market may be concealing big problems
-
Novo Nordisk launches multi-month subscriptions for Wegovy obesity drugs as it tries to catch up with Eli Lilly
-
Amylyx Pharmaceuticals (AMLX) Winds Up Avexitide Phase 3 Lucidity Trial Enrollment
-
Is Collegium Pharmaceutical (COLL) One of the Best Small-Cap Drug Manufacturers
-
What Makes Bausch Health (BHC) Appear So Attractive
-
Pacira (PCRX) BioSciences Well-Positioned With Genicular Outcomes Registry Evidence
-
Ironwood (IRWD) is One of the Most Attractive Small-Cap Drug Manufacturers, Here is Why
-
Aquestive Therapeutics (AQST) Awaits Anaphylm NDA Approval in Q3
-
BGE-102 Data Inspires Confidence for BioAge Labs (BIOA)
-
Accounting firm Withum launches unified client portal with Aiwyn
-
FASB appoints four new members to investor advisory committee
-
The ECB’s three-pronged monetary strategy
-
Nearly half of Americans fear a total economic collapse — here’s what that would actually mean for you
-
DHS resumes asylum decisions. And, Iran’s strike injures over 12 U.S. personnel
-
Banking on Resilience: Building a Resilient, Intelligent Bank in the AI Era – New Celent report alert
2026-02-05
































